AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ERYTHROMYCIN ESTOLATE
29 registrations across 6 African markets— 20 active
Markets with ERYTHROMYCIN ESTOLATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ERYTHROMYCIN ESTOLATE SUSPENSION; ORAL | 🇿🇼Zimbabwe | MEDICAMEN BIOTECH LIMITED | active | Jan 2030 |
| Galthrox 125 oral suspension Suspension for Oral Use | 🇿🇲Zambia | GALPHA LABORATORIES LIMITED | active | Jun 2029 |
| ENAMYCIN SUSPENSION | 🇬🇭Ghana | Ernest Chemist Limited | active | May 2028 |
| ENAMYCIN SUSPENSION | 🇬🇭Ghana | Ernest Chemist Limited | active | May 2028 |
| ERYTHROKIN TABLETS | 🇬🇭Ghana | KINAPHARMA LIMITED, P.O.BOX, 241, TRADE FAIR, LA, ACCRA, GHANA | active | Dec 2027 |
| ERYTHROKIN TABLETS | 🇬🇭Ghana | KINAPHARMA LIMITED, P.O.BOX, 241, TRADE FAIR, LA, ACCRA, GHANA | active | Dec 2027 |
| LILLY-ERYTHROMYCIN 250 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| ERYCACH 125MG/5ML SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2024 |
| ERYCACH_250 250MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| ERYTHROMYCIN_ESTOLATE 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2016 |
| ERYTHROMYCIN_ESTOLATE 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2012 |
| ERYCIN 125ML/5ML ORAL SUSPENSION ORAL SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2011 |
| ESTOMED-125 125MG/5ML SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2010 |
| BETAMYCIN 125MG/5ML SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Nov 2004 |
| ERYC 125MG/5ML SYRUP SYRUP | 🇲🇼Malawi | — | expired | Feb 2003 |
| ERYTHROMYCIN
ESTOLATE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | PROFARMA .SH.A | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | KAMPALA PHARMACEUTICA L INDUSTRIES LTD | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | PROFARMA .SH.A | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | PROFARMA .SH.A | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | KAMPALA PHARMACEUTICA L INDUSTRIES LTD | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL LIQUID
ORDINARY
SUSPENSIONS | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | KAMPALA PHARMACEUTICA L INDUSTRIES LTD | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | KAMPALA PHARMACEUTICA L INDUSTRIES LTD | active | — |
| ERYTHROMYCIN ESTOLATE | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL LIQUID
ORDINARY
SUSPENSIONS | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL LIQUID
ORDINARY
SUSPENSIONS | 🇺🇬Uganda | ROYAL PHARMA 2011 LIMITED | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL LIQUID
ORDINARY
SUSPENSIONS | 🇺🇬Uganda | ROYAL PHARMA 2011 LIMITED | active | — |
| ERYTHROMYCIN
ESTOLATE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | PROFARMA .SH.A | active | — |
| ERYTHROMYCIN ESTOLATE | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
ERYTHROMYCIN ESTOLATE in Africa — Regulatory Overview
ERYTHROMYCIN ESTOLATE is registered across 6 African markets with 29 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Ghana, South Africa and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 29 registrations, 20 (69%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.